Summary
Dr. George Tidmarsh, who led the FDA’s drug center, resigned after federal officials began looking into serious concerns about his conduct. His resignation coincided with a lawsuit from a drug company claiming he made damaging statements about them while at the FDA. The lawsuit accuses Tidmarsh of using his position to pursue a personal grudge.
Key Facts
- Dr. George Tidmarsh resigned from the FDA’s drug center after officials started investigating his conduct.
- Tidmarsh was placed on leave before his resignation following concerns raised to the Department of Health and Human Services.
- Aurinia Pharmaceuticals filed a lawsuit claiming Tidmarsh made false comments using his FDA role.
- The lawsuit alleges Tidmarsh targeted the company's chair due to previous business conflicts.
- Tidmarsh's LinkedIn post about Aurinia's product led to a significant drop in the company’s stock value.
- The FDA's drug center, which Tidmarsh oversaw, is the largest part of the agency and has seen significant staff losses recently.
- Before joining the FDA, Tidmarsh worked in pharmaceuticals and has a background in academia.
